1-4 of 4
Andreas Grüneisen
Close
Sort by
Journal Articles

Outcome of Myelodysplastic Syndrome Treated with Intensive Chemotherapy within the AMLCG99 Trial

Utz Krug, MD, Carsten Muller-Tidow, MD, Matthias Stelljes, Maria Cristina Sauerland, MSc, Achim Heinecke, Ph.D., Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Jan Braess, MD, Karsten Spiekermann, MD, Sarah Volpert, PhD, Peter Staib, Andreas Grüneisen, MD, Wolfgang Kern, MD, Albrecht Reichle, MD, Wolf-Dieter Ludwig, Leopold Balleisen, MD, Hartmut Eimermacher, MD, Carlo Aul, MD, Herbert Rasche, MD, Eva Lengfelder, MD, Eckhard Thiel, Joachim Kienast, Hubert Serve, MD, Bernhard Josef Woermann, MD, Wolfgang Hiddemann, MD, Wolfgang E. Berdel, Thomas Buchner, MD
Journal: Blood
Blood (2011) 118 (21): 2773.
https://doi.org/10.1182/blood.V118.21.2773.2773
Published: 2011
Journal Articles

Long-Term Results in Patients with Acute Myeloid Leukemia (AML): The Influence of High-Dose AraC, G-CSF Priming, Autologous Transplantation, Prolonged Maintenance, Age, History, Cytogenetics, and Mutation Status. Data of the AMLCG 1999 Trial.

Thomas Buchner, Wolfgang E. Berdel, Claudia Haferlach, Susanne Schnittger, PhD, Torsten Haferlach, Hubert Serve, Carsten Müller-Tidow, Jan Braess, Karsten Spiekermann, Joachim Kienast, Rolf Mesters, Sarah Volpert, Peter Staib, Andreas Grüneisen, Wolfgang Kern, MD, Albrecht Reichle, Wolf-Dieter Ludwig, Georg Maschmeyer, Leopold Balleisen, Hartmut Eimermacher, Carlo Aul, Aristoteles Giagounidis, Herbert Rasche, Rüdiger Hehlmann, Eva Lengfelder, Wolfgang Köpcke, Utz O. Krug, Maria Cristina Sauerland, Achim Heinecke, Bernhard J Woermann, Wolfgang Hiddemann
Journal: Blood
Blood (2009) 114 (22): 485.
https://doi.org/10.1182/blood.V114.22.485.485
Published: 2009
Journal Articles

Older Age Is An Independent Risk Factor in AML

Thomas Buchner, Wolfgang E. Berdel, Claudia Haferlach, Susanne Schnittger, Torsten Haferlach, MD, Hubert Serve, Carsten Müller-Tidow, Jan Braess, Karsten Spiekermann, Joachim Kienast, Rolf Mesters, Sarah Volpert, Peter Staib, Andreas Grüneisen, Wolfgang Kern, Albrecht Reichle, Wolf-Dieter Ludwig, Georg Maschmeyer, Ludwig Balleisen, Hartmut Eimermacher, Carlo Aul, Aristoteles Giagounidis, Herbert Rasche, Ruediger Hehlmann, Eva Lengfelder, Wolfgang Koepcke, Utz O. Krug, Maria Cristina Sauerland, Achim Heinecke, Bernhard Josef Woermann, Wolfgang Hiddemann, MD
Journal: Blood
Blood (2008) 112 (11): 555.
https://doi.org/10.1182/blood.V112.11.555.555
Published: 2008
Journal Articles

BCR-ABL P-Loop Deletion Detected in Imatinib-Resistant CML Patients Corresponds to Splice Variant Associated with L248V Point Mutation, Retains BCR-ABL Kinase Activity, and Responds to Dasatinib Treatment.

Nikolas von Bubnoff, MD, Philipp Erben, MD, Martin Müller, MD, Tanja Lahaye, MD, Susanne Schnittger, MD, Frank Schlegel, MD, Hubert Serve, MD, Andreas Grüneisen, MD, Rudiger Hehlmann, MD, Christian Peschel, MD, Justus Duyster, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2006) 108 (11): 2168.
https://doi.org/10.1182/blood.V108.11.2168.2168
Published: 2006